Spotlight on Neuro-2a
Learn more about this cell line in our scientific spotlights:
Neuroblastoma is the most prevalent solid tumor in childhood and the most common tumor in infants less than 1 year of age. In spite of aggressive multimodal therapeutic approaches, the five-year survival rate in patients with highrisk neuroblastoma remains poor at <50%.